The global Immortalized Human Cells market was valued at US$ 1577 million in 2025 and is anticipated to reach US$ 3407 million by 2032, at a CAGR of 11.8% from 2026 to 2032.

Immortalized Human Cells Market

The global volume of technical services related to immortalized human cells reached approximately 3.72 million projects in 2024, with an average customer price of $403.15 per project. Immortalized human cells are human cell lines with unlimited proliferative capacity obtained through genetic engineering techniques. Related technical services include cell line establishment, gene editing, functional validation, drug screening, and customized culture. These services provide crucial technology platforms and solutions for drug development, disease modeling, and biomedical research, significantly enhancing research efficiency and reliability.

The technical service market for immortalized human cells is currently in a critical phase of rapid professionalization and standardization. The market's current state is characterized by growing demand for regulatory-compliant standardized cell line establishment, complex gene editing, and high-quality functional validation services, driven by the needs of precision medicine and personalized therapies. Professional CRO companies and large biotechnology firms dominate the market by establishing standardized technology platforms and quality systems. The development trend is clearly directed towards higher throughput and more precise technical services, including the integration of innovative services such as automated screening platforms, multi-omics analysis integration, and AI-assisted cell phenotype analysis. The prevailing market view is that future competition will extend beyond basic technical services to focus more on the capability to provide integrated solutions, data quality and depth of analytical value, and the completeness of technical systems meeting stringent regulatory requirements. Meanwhile, balancing service standardization with personalized needs will become a significant challenge for enterprises.

This report delivers a comprehensive overview of the global Immortalized Human Cells market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Immortalized Human Cells. The Immortalized Human Cells market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Immortalized Human Cells market comprehensively. Regional market sizes by Type, by Application, by Source, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Immortalized Human Cells manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Immortalized Human Cells Market Report

Report Metric	Details
Report Name	Immortalized Human Cells Market
Accounted market size in 2025	US$ 1577 million
Forecasted market size in 2032	US$ 3407 million
CAGR	11.8%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Ready-to-use Customized
Segment by Source	Liver-Derived Kidney-Derived Nervous System-Derived Other
Segment by Identity	Identified Samples Anonymized Samples
Segment by Application	Medical Research Vaccine Development Gene Therapy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Ispecimen, ABO Bio, AnaBios, Biomedica Cro, Bioivt, Iprocess, Crown Bioscience, Biomex, PrecisionMed, Cureline, DX Biosamples, Audubon, Precision for Medicine, Discovery Life Sciences, ProteoGenex, CGT Global
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Source, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Immortalized Human Cells companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Immortalized Human Cells Market growing?

Ans: The Immortalized Human Cells Market witnessing a CAGR of 11.8% during the forecast period 2026-2032.

What is the Immortalized Human Cells Market size in 2032?

Ans: The Immortalized Human Cells Market size in 2032 will be US$ 3407 million.

Who are the main players in the Immortalized Human Cells Market report?

Ans: The main players in the Immortalized Human Cells Market are Ispecimen, ABO Bio, AnaBios, Biomedica Cro, Bioivt, Iprocess, Crown Bioscience, Biomex, PrecisionMed, Cureline, DX Biosamples, Audubon, Precision for Medicine, Discovery Life Sciences, ProteoGenex, CGT Global

What are the Application segmentation covered in the Immortalized Human Cells Market report?

Ans: The Applications covered in the Immortalized Human Cells Market report are Medical Research, Vaccine Development, Gene Therapy, Other

What are the Type segmentation covered in the Immortalized Human Cells Market report?

Ans: The Types covered in the Immortalized Human Cells Market report are Ready-to-use, Customized

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Immortalized Human Cells Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Ready-to-use

1.2.3 Customized

1.3 Market by Source

1.3.1 Global Immortalized Human Cells Market Size Growth Rate by Source: 2021 vs 2025 vs 2032

1.3.2 Liver-Derived

1.3.3 Kidney-Derived

1.3.4 Nervous System-Derived

1.3.5 Other

1.4 Market by Identity

1.4.1 Global Immortalized Human Cells Market Size Growth Rate by Identity: 2021 vs 2025 vs 2032

1.4.2 Identified Samples

1.4.3 Anonymized Samples

1.5 Market by Application

1.5.1 Global Immortalized Human Cells Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Medical Research

1.5.3 Vaccine Development

1.5.4 Gene Therapy

1.5.5 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Immortalized Human Cells Market Perspective (2021–2032)

2.2 Global Immortalized Human Cells Growth Trends by Region

2.2.1 Global Immortalized Human Cells Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Immortalized Human Cells Historic Market Size by Region (2021–2026)

2.2.3 Immortalized Human Cells Forecasted Market Size by Region (2027–2032)

2.3 Immortalized Human Cells Market Dynamics

2.3.1 Immortalized Human Cells Industry Trends

2.3.2 Immortalized Human Cells Market Drivers

2.3.3 Immortalized Human Cells Market Challenges

2.3.4 Immortalized Human Cells Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Immortalized Human Cells Players by Revenue

3.1.1 Global Top Immortalized Human Cells Players by Revenue (2021–2026)

3.1.2 Global Immortalized Human Cells Revenue Market Share by Players (2021–2026)

3.2 Global Top Immortalized Human Cells Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Immortalized Human Cells Revenue

3.4 Global Immortalized Human Cells Market Concentration Ratio

3.4.1 Global Immortalized Human Cells Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Immortalized Human Cells Revenue in 2025

3.5 Global Key Players of Immortalized Human Cells Head Offices and Areas Served

3.6 Global Key Players of Immortalized Human Cells, Products and Applications

3.7 Global Key Players of Immortalized Human Cells, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Immortalized Human Cells Breakdown Data by Type

4.1 Global Immortalized Human Cells Historic Market Size by Type (2021–2026)

4.2 Global Immortalized Human Cells Forecasted Market Size by Type (2027–2032)

5 Immortalized Human Cells Breakdown Data by Application

5.1 Global Immortalized Human Cells Historic Market Size by Application (2021–2026)

5.2 Global Immortalized Human Cells Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Immortalized Human Cells Market Size (2021–2032)

6.2 North America Immortalized Human Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Immortalized Human Cells Market Size by Country (2021–2026)

6.4 North America Immortalized Human Cells Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Immortalized Human Cells Market Size (2021–2032)

7.2 Europe Immortalized Human Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Immortalized Human Cells Market Size by Country (2021–2026)

7.4 Europe Immortalized Human Cells Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Immortalized Human Cells Market Size (2021–2032)

8.2 Asia-Pacific Immortalized Human Cells Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Immortalized Human Cells Market Size by Region (2021–2026)

8.4 Asia-Pacific Immortalized Human Cells Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Immortalized Human Cells Market Size (2021–2032)

9.2 Latin America Immortalized Human Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Immortalized Human Cells Market Size by Country (2021–2026)

9.4 Latin America Immortalized Human Cells Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Immortalized Human Cells Market Size (2021–2032)

10.2 Middle East & Africa Immortalized Human Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Immortalized Human Cells Market Size by Country (2021–2026)

10.4 Middle East & Africa Immortalized Human Cells Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Ispecimen

11.1.1 Ispecimen Company Details

11.1.2 Ispecimen Business Overview

11.1.3 Ispecimen Immortalized Human Cells Introduction

11.1.4 Ispecimen Revenue in Immortalized Human Cells Business (2021–2026)

11.1.5 Ispecimen Recent Development

11.2 ABO Bio

11.2.1 ABO Bio Company Details

11.2.2 ABO Bio Business Overview

11.2.3 ABO Bio Immortalized Human Cells Introduction

11.2.4 ABO Bio Revenue in Immortalized Human Cells Business (2021–2026)

11.2.5 ABO Bio Recent Development

11.3 AnaBios

11.3.1 AnaBios Company Details

11.3.2 AnaBios Business Overview

11.3.3 AnaBios Immortalized Human Cells Introduction

11.3.4 AnaBios Revenue in Immortalized Human Cells Business (2021–2026)

11.3.5 AnaBios Recent Development

11.4 Biomedica Cro

11.4.1 Biomedica Cro Company Details

11.4.2 Biomedica Cro Business Overview

11.4.3 Biomedica Cro Immortalized Human Cells Introduction

11.4.4 Biomedica Cro Revenue in Immortalized Human Cells Business (2021–2026)

11.4.5 Biomedica Cro Recent Development

11.5 Bioivt

11.5.1 Bioivt Company Details

11.5.2 Bioivt Business Overview

11.5.3 Bioivt Immortalized Human Cells Introduction

11.5.4 Bioivt Revenue in Immortalized Human Cells Business (2021–2026)

11.5.5 Bioivt Recent Development

11.6 Iprocess

11.6.1 Iprocess Company Details

11.6.2 Iprocess Business Overview

11.6.3 Iprocess Immortalized Human Cells Introduction

11.6.4 Iprocess Revenue in Immortalized Human Cells Business (2021–2026)

11.6.5 Iprocess Recent Development

11.7 Crown Bioscience

11.7.1 Crown Bioscience Company Details

11.7.2 Crown Bioscience Business Overview

11.7.3 Crown Bioscience Immortalized Human Cells Introduction

11.7.4 Crown Bioscience Revenue in Immortalized Human Cells Business (2021–2026)

11.7.5 Crown Bioscience Recent Development

11.8 Biomex

11.8.1 Biomex Company Details

11.8.2 Biomex Business Overview

11.8.3 Biomex Immortalized Human Cells Introduction

11.8.4 Biomex Revenue in Immortalized Human Cells Business (2021–2026)

11.8.5 Biomex Recent Development

11.9 PrecisionMed

11.9.1 PrecisionMed Company Details

11.9.2 PrecisionMed Business Overview

11.9.3 PrecisionMed Immortalized Human Cells Introduction

11.9.4 PrecisionMed Revenue in Immortalized Human Cells Business (2021–2026)

11.9.5 PrecisionMed Recent Development

11.10 Cureline

11.10.1 Cureline Company Details

11.10.2 Cureline Business Overview

11.10.3 Cureline Immortalized Human Cells Introduction

11.10.4 Cureline Revenue in Immortalized Human Cells Business (2021–2026)

11.10.5 Cureline Recent Development

11.11 DX Biosamples

11.11.1 DX Biosamples Company Details

11.11.2 DX Biosamples Business Overview

11.11.3 DX Biosamples Immortalized Human Cells Introduction

11.11.4 DX Biosamples Revenue in Immortalized Human Cells Business (2021–2026)

11.11.5 DX Biosamples Recent Development

11.12 Audubon

11.12.1 Audubon Company Details

11.12.2 Audubon Business Overview

11.12.3 Audubon Immortalized Human Cells Introduction

11.12.4 Audubon Revenue in Immortalized Human Cells Business (2021–2026)

11.12.5 Audubon Recent Development

11.13 Precision for Medicine

11.13.1 Precision for Medicine Company Details

11.13.2 Precision for Medicine Business Overview

11.13.3 Precision for Medicine Immortalized Human Cells Introduction

11.13.4 Precision for Medicine Revenue in Immortalized Human Cells Business (2021–2026)

11.13.5 Precision for Medicine Recent Development

11.14 Discovery Life Sciences

11.14.1 Discovery Life Sciences Company Details

11.14.2 Discovery Life Sciences Business Overview

11.14.3 Discovery Life Sciences Immortalized Human Cells Introduction

11.14.4 Discovery Life Sciences Revenue in Immortalized Human Cells Business (2021–2026)

11.14.5 Discovery Life Sciences Recent Development

11.15 ProteoGenex

11.15.1 ProteoGenex Company Details

11.15.2 ProteoGenex Business Overview

11.15.3 ProteoGenex Immortalized Human Cells Introduction

11.15.4 ProteoGenex Revenue in Immortalized Human Cells Business (2021–2026)

11.15.5 ProteoGenex Recent Development

11.16 CGT Global

11.16.1 CGT Global Company Details

11.16.2 CGT Global Business Overview

11.16.3 CGT Global Immortalized Human Cells Introduction

11.16.4 CGT Global Revenue in Immortalized Human Cells Business (2021–2026)

11.16.5 CGT Global Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bioivt

Precision for Medicine

Discovery Life Sciences

ProteoGenex

CGT GLOBAL

List of Tables

Table 1. Global Immortalized Human Cells Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Ready-to-use

Table 3. Key Players of Customized

Table 4. Global Immortalized Human Cells Market Size Growth Rate by Source (US$ Million): 2021 vs 2025 vs 2032

Table 5. Key Players of Liver-Derived

Table 6. Key Players of Kidney-Derived

Table 7. Key Players of Nervous System-Derived

Table 8. Key Players of Other

Table 9. Global Immortalized Human Cells Market Size Growth Rate by Identity (US$ Million): 2021 vs 2025 vs 2032

Table 10. Key Players of Identified Samples

Table 11. Key Players of Anonymized Samples

Table 12. Global Immortalized Human Cells Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 13. Global Immortalized Human Cells Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 14. Global Immortalized Human Cells Market Size by Region (US$ Million), 2021–2026

Table 15. Global Immortalized Human Cells Market Share by Region (2021–2026)

Table 16. Global Immortalized Human Cells Forecasted Market Size by Region (US$ Million), 2027–2032

Table 17. Global Immortalized Human Cells Market Share by Region (2027–2032)

Table 18. Immortalized Human Cells Market Trends

Table 19. Immortalized Human Cells Market Drivers

Table 20. Immortalized Human Cells Market Challenges

Table 21. Immortalized Human Cells Market Restraints

Table 22. Global Immortalized Human Cells Revenue by Players (US$ Million), 2021–2026

Table 23. Global Immortalized Human Cells Market Share by Players (2021–2026)

Table 24. Global Top Immortalized Human Cells Players by Tier (Tier 1, Tier 2, and Tier 3), based on Immortalized Human Cells Revenue, 2025

Table 25. Ranking of Global Top Immortalized Human Cells Companies by Revenue (US$ Million) in 2025

Table 26. Global 5 Largest Players Market Share by Immortalized Human Cells Revenue (CR5 and HHI), 2021–2026

Table 27. Global Key Players of Immortalized Human Cells, Headquarters and Area Served

Table 28. Global Key Players of Immortalized Human Cells, Products and Applications

Table 29. Global Key Players of Immortalized Human Cells, Date of General Availability (GA)

Table 30. Mergers and Acquisitions, Expansion Plans

Table 31. Global Immortalized Human Cells Market Size by Type (US$ Million), 2021–2026

Table 32. Global Immortalized Human Cells Revenue Market Share by Type (2021–2026)

Table 33. Global Immortalized Human Cells Forecasted Market Size by Type (US$ Million), 2027–2032

Table 34. Global Immortalized Human Cells Revenue Market Share by Type (2027–2032)

Table 35. Global Immortalized Human Cells Market Size by Application (US$ Million), 2021–2026

Table 36. Global Immortalized Human Cells Revenue Market Share by Application (2021–2026)

Table 37. Global Immortalized Human Cells Forecasted Market Size by Application (US$ Million), 2027–2032

Table 38. Global Immortalized Human Cells Revenue Market Share by Application (2027–2032)

Table 39. North America Immortalized Human Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 40. North America Immortalized Human Cells Market Size by Country (US$ Million), 2021–2026

Table 41. North America Immortalized Human Cells Market Size by Country (US$ Million), 2027–2032

Table 42. Europe Immortalized Human Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Europe Immortalized Human Cells Market Size by Country (US$ Million), 2021–2026

Table 44. Europe Immortalized Human Cells Market Size by Country (US$ Million), 2027–2032

Table 45. Asia-Pacific Immortalized Human Cells Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 46. Asia-Pacific Immortalized Human Cells Market Size by Region (US$ Million), 2021–2026

Table 47. Asia-Pacific Immortalized Human Cells Market Size by Region (US$ Million), 2027–2032

Table 48. Latin America Immortalized Human Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 49. Latin America Immortalized Human Cells Market Size by Country (US$ Million), 2021–2026

Table 50. Latin America Immortalized Human Cells Market Size by Country (US$ Million), 2027–2032

Table 51. Middle East & Africa Immortalized Human Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 52. Middle East & Africa Immortalized Human Cells Market Size by Country (US$ Million), 2021–2026

Table 53. Middle East & Africa Immortalized Human Cells Market Size by Country (US$ Million), 2027–2032

Table 54. Ispecimen Company Details

Table 55. Ispecimen Business Overview

Table 56. Ispecimen Immortalized Human Cells Product

Table 57. Ispecimen Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026

Table 58. Ispecimen Recent Development

Table 59. ABO Bio Company Details

Table 60. ABO Bio Business Overview

Table 61. ABO Bio Immortalized Human Cells Product

Table 62. ABO Bio Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026

Table 63. ABO Bio Recent Development

Table 64. AnaBios Company Details

Table 65. AnaBios Business Overview

Table 66. AnaBios Immortalized Human Cells Product

Table 67. AnaBios Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026

Table 68. AnaBios Recent Development

Table 69. Biomedica Cro Company Details

Table 70. Biomedica Cro Business Overview

Table 71. Biomedica Cro Immortalized Human Cells Product

Table 72. Biomedica Cro Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026

Table 73. Biomedica Cro Recent Development

Table 74. Bioivt Company Details

Table 75. Bioivt Business Overview

Table 76. Bioivt Immortalized Human Cells Product

Table 77. Bioivt Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026

Table 78. Bioivt Recent Development

Table 79. Iprocess Company Details

Table 80. Iprocess Business Overview

Table 81. Iprocess Immortalized Human Cells Product

Table 82. Iprocess Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026

Table 83. Iprocess Recent Development

Table 84. Crown Bioscience Company Details

Table 85. Crown Bioscience Business Overview

Table 86. Crown Bioscience Immortalized Human Cells Product

Table 87. Crown Bioscience Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026

Table 88. Crown Bioscience Recent Development

Table 89. Biomex Company Details

Table 90. Biomex Business Overview

Table 91. Biomex Immortalized Human Cells Product

Table 92. Biomex Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026

Table 93. Biomex Recent Development

Table 94. PrecisionMed Company Details

Table 95. PrecisionMed Business Overview

Table 96. PrecisionMed Immortalized Human Cells Product

Table 97. PrecisionMed Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026

Table 98. PrecisionMed Recent Development

Table 99. Cureline Company Details

Table 100. Cureline Business Overview

Table 101. Cureline Immortalized Human Cells Product

Table 102. Cureline Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026

Table 103. Cureline Recent Development

Table 104. DX Biosamples Company Details

Table 105. DX Biosamples Business Overview

Table 106. DX Biosamples Immortalized Human Cells Product

Table 107. DX Biosamples Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026

Table 108. DX Biosamples Recent Development

Table 109. Audubon Company Details

Table 110. Audubon Business Overview

Table 111. Audubon Immortalized Human Cells Product

Table 112. Audubon Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026

Table 113. Audubon Recent Development

Table 114. Precision for Medicine Company Details

Table 115. Precision for Medicine Business Overview

Table 116. Precision for Medicine Immortalized Human Cells Product

Table 117. Precision for Medicine Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026

Table 118. Precision for Medicine Recent Development

Table 119. Discovery Life Sciences Company Details

Table 120. Discovery Life Sciences Business Overview

Table 121. Discovery Life Sciences Immortalized Human Cells Product

Table 122. Discovery Life Sciences Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026

Table 123. Discovery Life Sciences Recent Development

Table 124. ProteoGenex Company Details

Table 125. ProteoGenex Business Overview

Table 126. ProteoGenex Immortalized Human Cells Product

Table 127. ProteoGenex Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026

Table 128. ProteoGenex Recent Development

Table 129. CGT Global Company Details

Table 130. CGT Global Business Overview

Table 131. CGT Global Immortalized Human Cells Product

Table 132. CGT Global Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026

Table 133. CGT Global Recent Development

Table 134. Research Programs/Design for This Report

Table 135. Key Data Information from Secondary Sources

Table 136. Key Data Information from Primary Sources

Table 137. Authors List of This Report

List of Figures

Figure 1. Immortalized Human Cells Picture

Figure 2. Global Immortalized Human Cells Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Immortalized Human Cells Market Share by Type: 2025 vs 2032

Figure 4. Ready-to-use Features

Figure 5. Customized Features

Figure 6. Global Immortalized Human Cells Market Size Comparison by Source (US$ Million), 2021–2032

Figure 7. Liver-Derived Features

Figure 8. Kidney-Derived Features

Figure 9. Nervous System-Derived Features

Figure 10. Other Features

Figure 11. Global Immortalized Human Cells Market Size Comparison by Identity (US$ Million), 2021–2032

Figure 12. Identified Samples Features

Figure 13. Anonymized Samples Features

Figure 14. Global Immortalized Human Cells Market Size by Application (US$ Million), 2021–2032

Figure 15. Global Immortalized Human Cells Market Share by Application: 2025 vs 2032

Figure 16. Medical Research Case Studies

Figure 17. Vaccine Development Case Studies

Figure 18. Gene Therapy Case Studies

Figure 19. Other Case Studies

Figure 20. Immortalized Human Cells Report Years Considered

Figure 21. Global Immortalized Human Cells Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 22. Global Immortalized Human Cells Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Immortalized Human Cells Market Share by Region: 2025 vs 2032

Figure 24. Global Immortalized Human Cells Market Share by Players in 2025

Figure 25. Global Immortalized Human Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 26. The Top 10 and 5 Players Market Share by Immortalized Human Cells Revenue in 2025

Figure 27. North America Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. North America Immortalized Human Cells Market Share by Country (2021–2032)

Figure 29. United States Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Canada Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Europe Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Europe Immortalized Human Cells Market Share by Country (2021–2032)

Figure 33. Germany Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. France Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. U.K. Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Italy Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Russia Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Ireland Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Asia-Pacific Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Asia-Pacific Immortalized Human Cells Market Share by Region (2021–2032)

Figure 41. China Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Japan Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. South Korea Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Southeast Asia Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. India Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Australia & New Zealand Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Latin America Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Latin America Immortalized Human Cells Market Share by Country (2021–2032)

Figure 49. Mexico Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Brazil Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Middle East & Africa Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Middle East & Africa Immortalized Human Cells Market Share by Country (2021–2032)

Figure 53. Israel Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Saudi Arabia Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. UAE Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Ispecimen Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)

Figure 57. ABO Bio Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)

Figure 58. AnaBios Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)

Figure 59. Biomedica Cro Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)

Figure 60. Bioivt Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)

Figure 61. Iprocess Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)

Figure 62. Crown Bioscience Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)

Figure 63. Biomex Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)

Figure 64. PrecisionMed Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)

Figure 65. Cureline Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)

Figure 66. DX Biosamples Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)

Figure 67. Audubon Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)

Figure 68. Precision for Medicine Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)

Figure 69. Discovery Life Sciences Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)

Figure 70. ProteoGenex Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)

Figure 71. CGT Global Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Immortalized Cell Line Market Research Report 2024

Global Cell Line Generation Market Research Report 2025

Global Stem Cell and Primary Cell Culture Medium Market Insights Forecast to 2030

Global Regenerative Cell Market Research Report 2024

Cell Immortalization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cell Culture Consumables Market Research Report 2024

Global Cell and Gene Therapy Market Research Report 2024

Global Personalized Cell Therapy Market Research Report 2024

Research Use Human Cells Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Knockout Cell Lines Market Research Report 2025

Global Cell and Gene Therapy Services Market Research Report 2024

Global Cell Identification and Characterization Tests Market Research Report 2024

Global Cell Characterization Tests Market Research Report 2024

Global Cell Line Characterization Services Market Research Report 2024

Global Cell Immortalization Reagent Market Research Report 2025

Global Cell Identification and Characterization Testing Services Market Research Report 2024

Global Cell Bank Market Research Report 2024

Global Human Over expression Lysate Market Research Report 2024

Global Cell Cultured Meat Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions